InVivoMAb Anti-Human CXCL4/ PF4/(Iv0086) (ARO-A13289)

概述
图片
参考文献

概述

货号	ARO-A13289
品牌	ProteoGenix
描述	InVivoMAb Anti-Human CXCL4/ PF4/(Iv0086) [Iv0086] (ARO-A13289) is a human monoclonal antibody detecting C-X-C motif chemokine 4, PF-4, Oncostatin-A, Endothelial cell growth inhibitor, CXCL4, Iroplact, Platelet factor 4, PF4, SCYB4 in ELISA, Neutralization. Suitable for Human. Highlights Protein A/G purified from cell culture supernatant. — Ensuring high specificity and minimal background. Multi-Application — Validated across multiple applications.
种属反应性	Human
应用	ELISA, Neutralization
宿主	Human
同种型	IgG1, kappa
克隆号	Iv0086
克隆类型	Monoclonal
靶标	C-X-C motif chemokine 4, PF-4, Oncostatin-A, Endothelial cell growth inhibitor, CXCL4, Iroplact, Platelet factor 4, PF4, SCYB4
内毒素水平	Please contact with the lab for this information.
纯度	>95% as determined by SDS-PAGE.
相关产品	pH 7.4 Dilution Buffer
纯化方式	Protein A/G purified from cell culture supernatant.
Accession号	P02776
状态	Liquid
保存溶液	0.01M PBS, pH 7.4. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
稳定性和存储	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
背景	Platelet factor 4 (CXCL4/PF4) is a ~10 kDa protein. Chemokine released during platelet aggregation that plays a role in different biological processes including hematopoiesis, cell proliferation, differentiation, and activation. Acts via different functional receptors including CCR1, CXCR3A or CXCR3B. Upon interaction with CXCR3A receptor, induces activated T-lymphocytes migration mediated via downstream Ras/extracellular signal-regulated kinase (ERK) signaling. Neutralizes the anticoagulant effect of heparin by binding more strongly to heparin than to the chondroitin-4-sulfate chains of the carrier molecule. Plays a role in the inhibition of hematopoiesis and in the maintenance of hematopoietic stem cell (HSC) quiescence. 1. Fox, JM. et al. (2018) Scientific reports 8, 9466. PMID: 29930254 2. Lecomte-Raclet, L. et al. (1998) Blood 91, 2772-80. PMID: 9531587 3. Mueller, A. et al. (2008) Journal of leukocyte biology 83, 875-82. PMID: 18174362 4. Van Raemdonck, K. et al. (2014) Angiogenesis 17, 631-40. PMID: 24469069 5. Yang, C. et al. (2022) Nature communications 13, 3426. PMID: 35701499 6. Affandi, AJ. et al. (2022) Cell reports 38, 110189. PMID: 34986347 7. Dudek, AZ. et al. (1997) The Journal of biological chemistry 272, 31785-92. PMID: 9395524
Note	For research use only. Not suitable for clinical or therapeutic use.

图片

参考文献

公式

质量 (g) = 浓度 (mol/L) × 体积 (L) × 分子量 (g/mol)

填写 质量、浓度、体积中的任意 2 项 + 分子量，自动计算未知值。

质量

浓度

体积

分子量 *

g/mol

公式

C₁ × V₁ = C₂ × V₂

填写 4 项中的任意 3 项，自动计算未知值。

母液

C₁ (起始浓度)

V₁ (起始体积)

工作液

C₂ (终浓度)

V₂ (终体积)

重组蛋白

抗体

试剂盒

实验相关试剂

InVivoMAb Anti-Human CXCL4/ PF4/(Iv0086) (ARO-A13289)

概述

图片

参考文献

相关产品推荐

重组蛋白

抗体

试剂盒

实验相关试剂

InVivoMAb Anti-Human CXCL4/ PF4/(Iv0086) (ARO-A13289)

概述

图片

参考文献

相关产品推荐

获取报价